相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PML enhances the regulation of p53 by CK1 in response to DNA damage
O. Alsheich-Bartok et al.
ONCOGENE (2008)
Functional evolution of the p53 regulatory network through its target response elements
Anil G. Jegga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72
M. Reinbold et al.
ONCOGENE (2008)
Mutant p53 R270H gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis
Christina Heinlein et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Contribution of membrane localization to the apoptotic activity of PUMA
Karen S. Yee et al.
APOPTOSIS (2008)
DNA damage signalling guards against activated oncogenes and tumour progression
J. Bartek et al.
ONCOGENE (2007)
Mutant p53 attenuates the SMAD-dependent transforming growth factor β1 (TGF-β1) signaling pathway by repressing the expression of TGF-β receptor type II
Eyal Kalo et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Inflammation and cancer: An ancient link with novel potentials
S. Perwez Hussain et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity
Lynette Moore et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2007)
The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP
Fiamma Mantovani et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Quantitative analyses reveal the importance of regulated Hdmx degradation for P53 activation
Yunyuan V. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices
Gilles Gadea et al.
JOURNAL OF CELL BIOLOGY (2007)
Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture
Sabine Roman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
p53 therapy in a patient with Li-Fraumeni syndrome
Neil Senzer et al.
MOLECULAR CANCER THERAPEUTICS (2007)
TP53 mutations in human cancers:: functional selection and impact on cancer prognosis and outcomes
A. Petitjean et al.
ONCOGENE (2007)
A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1
Daniel Menendez et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome
Uri Tabori et al.
CANCER RESEARCH (2007)
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families
Maria Isabel Waddington Achatz et al.
CANCER LETTERS (2007)
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Anita Langerod et al.
BREAST CANCER RESEARCH (2007)
E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation
Laurent Le Cam et al.
CELL (2006)
Inactivation of the p53 pathway in retinoblastoma
Nikia A. Laurie et al.
NATURE (2006)
Structural basis for understanding oncogenic p53 mutations and designing rescue drugs
Andreas C. Joerger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome
G. Bougeard et al.
JOURNAL OF MEDICAL GENETICS (2006)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
Core domain interactions in full-length p53 in solution
DB Veprintsev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A twist for survival and cancer progression
A Puisieux et al.
BRITISH JOURNAL OF CANCER (2006)
Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome
P Wong et al.
GASTROENTEROLOGY (2006)
Tumor-derived p53 mutants induce NF-κB2 gene expression
MJ Scian et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice
F Krepulat et al.
ONCOGENE (2005)
Crystal structure of a superstable mutant of human p53 core domain - Insights into the mechanism of rescuing oncogenic mutations
AC Joerger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene
G Bougeard et al.
ONCOGENE (2003)
The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults
P Zacchi et al.
NATURE (2002)
Regulation of Cdc42-mediated morpholigical effects:: a novel function for p53
G Gadéa et al.
EMBO JOURNAL (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma
RC Ribeiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
